+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Automation in Biopharma Industry Report 2023-2033 - Product Thumbnail Image

Automation in Biopharma Industry Report 2023-2033

  • Report
  • March 2023
  • 396 Pages
  • Global
From
Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Mantle Cell Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Anti-Retroviral Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Anti-Retroviral Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • January 2025
  • 95 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 194 Pages
  • Global
From
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA - Product Thumbnail Image

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA

  • Report
  • December 2025
  • 123 Pages
  • United States
From
T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035 - Product Thumbnail Image

T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of Therapies, Industry Trends and Global Forecasts to 2035

  • Report
  • March 2025
  • 1048 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Market 2026-2030 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Market 2026-2030

  • Report
  • January 2026
  • 281 Pages
  • Global
From
HIV Injections Market - Global Strategic Business Report - Product Thumbnail Image

HIV Injections Market - Global Strategic Business Report

  • Report
  • March 2026
  • 182 Pages
  • Global
From
Thyroid Cancer Drugs Market Report 2026 - Product Thumbnail Image

Thyroid Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031 - Product Thumbnail Image

U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031

  • Drug Pipelines
  • February 2026
  • 3300 Pages
  • United States
From
Anti-Retroviral Drugs Market - Growth, Trends, COVID-19 and Forecasts (2023-2028) - Product Thumbnail Image

Anti-Retroviral Drugs Market - Growth, Trends, COVID-19 and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Regenerative Medicine Market Report 2023-2033 - Product Thumbnail Image

Regenerative Medicine Market Report 2023-2033

  • Report
  • March 2023
  • 232 Pages
  • Global
From
NASH Biomarkers (Non alcoholic Steatohepatitis) Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Thumbnail Image

NASH Biomarkers (Non alcoholic Steatohepatitis) Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • October 2023
  • 146 Pages
  • Global
From
Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Inflammatory Bowel Disease (IBD) Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 504 Pages
  • Global
From
Ulcerative Colitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ulcerative Colitis Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 181 Pages
  • Global
From
Immuno-Oncology - Global Strategic Business Report - Product Thumbnail Image

Immuno-Oncology - Global Strategic Business Report

  • Report
  • March 2026
  • 224 Pages
  • Global
From
Precision Oncology Market - Global Strategic Business Report - Product Thumbnail Image

Precision Oncology Market - Global Strategic Business Report

  • Report
  • March 2026
  • 382 Pages
  • Global
From
Hepatocellular Carcinoma Drugs Market Report 2026 - Product Thumbnail Image

Hepatocellular Carcinoma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cellular Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Cellular Immunotherapy - Global Strategic Business Report

  • Report
  • March 2026
  • 386 Pages
  • Global
From
Liver Diseases Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Liver Diseases Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • January 2026
  • 125 Pages
  • Global
From
Loading Indicator